REQUEST A DEMO
Total
USD $0.00
Search more companies

Magistra C&C SRL (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Magistra C&C SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

magistra c&c, constanta, headquartered in Romania, operates in the pharmaceutical industry, focusing on research, production, and distribution of human generic medicines. They offer a range of products, including Betahistin MCC tablets, and have a production capacity of 700 million tablets and 50 million suppositories and ovules per year. magistra c&c, constanta also engages in contract manufacturing and claims to have a presence in various international markets.

Headquarters
Bulevardul Aurel Vlaicu Nr. 82A
CONSTANTA; Constanta;

Contact Details: Purchase the Magistra C&C SRL report to view the information.

Website: http://www.magistracc.com

Basic Information
Total Employees:
Purchase the Magistra C&C SRL report to view the information.
Outstanding Shares:
Purchase the Magistra C&C SRL report to view the information.
Registered Capital:
Purchase the Magistra C&C SRL report to view the information.
Incorporation Date:
May 21, 1993
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
55%
Purchase this report to view the information.
22.5%
Purchase this report to view the information.
22.5%
Company Performance
Financial values in the chart are available after Magistra C&C SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
28.03%
Total operating revenue
27.35%
Operating profit (EBIT)
20.4%
EBITDA
15.82%
Net Profit (Loss) for the Period
157.44%
Total assets
12.34%
Total equity
18.29%
Operating Profit Margin (ROS)
-1.63%
Net Profit Margin
2.56%
Return on Equity (ROE)
8.36%
Debt to Equity Ratio
18.07%
Quick Ratio
0.2%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?